Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

63.63 +2.26 (+3.68%)

Streaming Delayed Price Updated: 3:26 PM EST, Dec 31, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,290,908
Open	61.12
Bid (Size)	63.58 (200)
Ask (Size)	63.65 (200)
Prev. Close	61.37
Today's Range	60.93 - 64.43
52wk Range	29.31 - 70.98
Shares Outstanding	95,640,600
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

Today 14:16 EST

As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the...

Via MarketMinute

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

December 30, 2025

From Grabar Law Office

Via GlobeNewswire

Performance

YTD	+30.0%	+30.0%
1 Month	-3.6%	-3.6%
3 Month	+15.8%	+15.8%
6 Month	+89.1%	+89.1%
1 Year	+35.0%	+35.0%

More News

Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); Cytokinetics, Inc. (NASDAQ: CYTK); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your

December 29, 2025

From Grabar Law Office

Via GlobeNewswire

Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Holley Inc. (NYSE: HLLY); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

December 22, 2025

From Grabar Law Office

Via GlobeNewswire

Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious? ↗

December 19, 2025

Via Stocktwits

This Cytokinetics Director Sold 5,000 Shares in November. Is It Time to Dump the Biopharmaceutical Stock? ↗

December 19, 2025

Via The Motley Fool

December 19, 2025

From Grabar Law Office

Via GlobeNewswire

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf

December 16, 2025

From Grabar Law Office

Via GlobeNewswire

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

December 12, 2025

From Grabar Law Office

Via GlobeNewswire

Notice For Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf

December 09, 2025

From Grabar Law Office

Via GlobeNewswire

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares ↗

December 08, 2025

Via The Motley Fool

Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

December 08, 2025

From Grabar Law Office

Via GlobeNewswire

Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

December 04, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims

December 02, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf

December 01, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Inspire Medical Systems, Inc. (NYSE: INSP); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on

November 26, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and Stride, Inc. (NYSE: LRN): Grabar Law Office is Investigating Claims on Your Behalf

November 24, 2025

From Grabar Law Office

Via GlobeNewswire

November 19, 2025

From Grabar Law Office

Via GlobeNewswire

What Does the Market Think About Cytokinetics Inc? ↗

November 18, 2025

Via Benzinga

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); enCore Energy Corp. (NASDAQ: EU); Fluor Corporation (NYSE: FLR); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating

November 18, 2025

From Grabar Law Office

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Urgently Reminds Investors of Cytokinetics, Quanex, Freeport, and Primo Brands to Contact the Firm About their Rights

November 17, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

November 17, 2025

Via NewMediaWire

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

November 17, 2025

Via TheNewswire.com

CYTK FINAL DEADLINE: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit

November 17, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm

November 17, 2025

From Schall Law

Via GlobeNewswire

Frequently Asked Questions

Is Cytokinetics, Incorporated - Common Stock publicly traded?

Yes, Cytokinetics, Incorporated - Common Stock is publicly traded.

What exchange does Cytokinetics, Incorporated - Common Stock trade on?

Cytokinetics, Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cytokinetics, Incorporated - Common Stock?

The ticker symbol for Cytokinetics, Incorporated - Common Stock is CYTK on the Nasdaq Stock Market

What is the current price of Cytokinetics, Incorporated - Common Stock?

The current price of Cytokinetics, Incorporated - Common Stock is 63.63

When was Cytokinetics, Incorporated - Common Stock last traded?

The last trade of Cytokinetics, Incorporated - Common Stock was at 12/31/25 03:26 PM ET

What is the market capitalization of Cytokinetics, Incorporated - Common Stock?

The market capitalization of Cytokinetics, Incorporated - Common Stock is 6.09B

How many shares of Cytokinetics, Incorporated - Common Stock are outstanding?

Cytokinetics, Incorporated - Common Stock has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.